Human Viral Vaccine Technology
2021-11-27 14:12
Vaccines are microorganisms or their products processed artificially, which, when inoculated into the body, can stimulate the immune system to produce antibodies and cells specifically targeting certain viruses or bacteria, enabling the body to develop resistance to the pathogen. Human viral vaccines mainly include live attenuated vaccines, inactivated vaccines, and viral vector vaccines, and the production processes of these types of vaccines are similar.
Virus isolation and purification mainly utilize the characteristic that virus particles are much larger than proteins and peptides, employing a combination of membrane separation technology and chromatography separation technology to ultimately obtain high-purity virus particles.
Common virus particle purification processes first remove cell debris from the fermentation broth through microporous filtration, then concentrate the sample via ultrafiltration to reduce volume and remove impurities such as HCP. After that, gel filtration chromatography and anion exchange chromatography are used for further purification, followed by ultrafiltration and diafiltration for concentration adjustment and buffer exchange to obtain the stock solution.
The Truking source innovative purification process replaces gel filtration chromatography and anion exchange chromatography with a single-step affinity chromatography based on traditional purification processes, achieving virus particle separation and purification.
